Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
2
×
akcea therapeutics
alnylam pharmaceuticals
amarin
attack
barry greene
boston
boston blog main
boston top stories
boston university
cardiovascular
cholesterol
clinical trials
dan ollendorf
david maron
diabetes
drugs
eicosapentaenoic acid
fda
fish oil
heart disease
hereditary transthyretin amyloidosis
inotersen
john berk
john thero
ldl
lovaza
mary o'donnell
mineral oil
new york
omacor
patisiran
reduce-it
regeneron pharmaceuticals
rna interference
What
ago
2
×
abuzz
alnylam
amarin
approve
awaits
big
biological
clinical
community
crossed
decades
decision
deeper
discovered
dive
doctors
eager
fda
fingers
fish
friday
gives
historic
medical
medicine
months
oil
patients
ponder
prescription
reduce
risk
rna
showed
study
supplement
time
trick
uses
Language
Current search:
ago
×
biotech
×
" new york top stories "
×
@xconomy.com
5 years ago
Deeper Dive: Amarin Fish-Oil Study Gives Eager Doctors More to Ponder
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
